Wtach SCCA’s Dr. Petros Grivas discuss the phase III JAVELIN Bladder 100 Trial, to be presented at ASCO plenary session. More information on results of this clinical trial can be viewed here.
From May 29 - May 31, the American Society of Clinical Oncology (ASCO) will host its annual meeting, showcasing important scientific insights from around the world. While this year's meeting is virtual, more than 20 world-class physicians and researchers from Seattle Cancer Care Alliance (SCCA) and our partner organizations will be presenting their pioneering research.
From a giant of cancer care to clinical trials that are instrumental in changing the way patients are treated, SCCA is a leader in turning scientific discovery into exciting new treatments.